Author:
Casey J L,Napier M P,King D J,Pedley R B,Chaplin L C,Weir N,Skelton L,Green A J,Hope-Stone L D,Yarranton G T,Begent R H J
Publisher
Springer Science and Business Media LLC
Reference30 articles.
1. Adair JA, Bodmer MW, Mountain A, Owens RJ (1992) International patent application. CDR grafted anti-CEA antibodies and their production. WO 92/01059.
2. Begent RHJ, Chester KA, Connors T, Crowther D, Fox B, Griffiths E, Hince TA, Lederman JA, McVie JG, Minor P, Secher DS, Schwartsmann G, Thorpe R, Wilbin C, Zwierzina H (1993) Cancer Research Campaign Operation Manual for control recommendations for products derived from recombinant DNA technology prepared for investigational administration to patients with cancer in phase I trials. Eur J Cancer 29A: 1907–1910
3. Begent RHJ, Verhaar MJ, Chester KA, Casey JL, Green AJ, Napier MP, Hope-Stone L, Cushen N, Keep PA, Johnson CJ, Hawkins RE, Hilson AJW, Robson L (1996) Clinical evidence of efficient tumour targeting based on single-chain Fv antibody selected from a combinatorial library. Nature Medicine 2: 979–984
4. Behr TM, Sharkey RM, Juweid MI, Dunn RM, Zhiliang Y, Zhang CH, Siegel JA, Gold DV, Goldenberg DM (1996) Factors influencing the pharmacokinetics, dosimetry and diagnostic accuracy of radioimmunodetection and radioimmunotherapy of carcinoembryonic antigen-expressing tumours. Cancer Res 56: 1805–1816
5. Borrebaeck CAK, Danielsson L, Ohlin M, Carlsson J, Carlsson R (1990) The use of in vitro immunisation cloning of variable regions and SCID mice for the production of human monoclonal antibodies. In Therapeutic monoclonal antibodies pp 1–15, UK: Stockton Press
Cited by
41 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献